The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
According to a model, the more favorable sequence for pediatric kidney transplantation is receipt of a living donor allograft first, followed by a deceased donor allograft, rather than the reverse order.
Race coefficients applied to calculation of eGFR in non-Black transplant candidates to demonstrate more equitable preemptive listing
Kidney transplant recipients who received their organs from donors who died from cardiovascular causes or experienced brain death had similar long-term graft survival and function.
Findings support the use of a fourth COVID-19 vaccine dose in kidney transplant recipients who don’t respond to standard 2-dose vaccination plus 1 booster.
Purpura and ulcers were the most frequent form of clinical presentation of calciphylaxis.
Risk for breakthrough infection higher for those with immunocompromising conditions, such as HIV, rheumatoid arthritis, solid organ transplant
After loss of the first allograft, survival time longer with timely second kidney transplant versus remaining wait-listed and on dialysis
Vaccinated kidney transplant recipients show impaired neutralization against emerging COVID-19 variants of concern.
One dose of Evusheld is administered as 2 separate, consecutive injections and may be effective for 6 months
